- Home
- BIRK vs ASND Comparison
BIRK vs ASND Comparison
Compare BIRK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIRK
- ASND
- Stock Information
- Founded
- BIRK 1774
- ASND 2006
- Country
- BIRK United Kingdom
- ASND Denmark
- Employees
- BIRK N/A
- ASND N/A
- Industry
- BIRK
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- BIRK
- ASND Health Care
- Exchange
- BIRK Nasdaq
- ASND Nasdaq
- Market Cap
- BIRK 8.8B
- ASND 10.6B
- IPO Year
- BIRK 2023
- ASND 2015
- Fundamental
- Price
- BIRK $48.82
- ASND $174.18
- Analyst Decision
- BIRK Strong Buy
- ASND Strong Buy
- Analyst Count
- BIRK 10
- ASND 17
- Target Price
- BIRK $69.00
- ASND $220.06
- AVG Volume (30 Days)
- BIRK 1.9M
- ASND 399.8K
- Earning Date
- BIRK 08-28-2025
- ASND 09-02-2025
- Dividend Yield
- BIRK N/A
- ASND N/A
- EPS Growth
- BIRK 152.58
- ASND N/A
- EPS
- BIRK 1.45
- ASND N/A
- Revenue
- BIRK $2,114,754,647.00
- ASND $398,509,511.00
- Revenue This Year
- BIRK $19.19
- ASND $75.05
- Revenue Next Year
- BIRK $15.95
- ASND $78.14
- P/E Ratio
- BIRK $33.62
- ASND N/A
- Revenue Growth
- BIRK 19.89
- ASND 12.06
- 52 Week Low
- BIRK $40.56
- ASND $111.09
- 52 Week High
- BIRK $64.78
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- BIRK 33.97
- ASND 55.04
- Support Level
- BIRK $48.34
- ASND $167.52
- Resistance Level
- BIRK $50.28
- ASND $180.78
- Average True Range (ATR)
- BIRK 1.34
- ASND 5.72
- MACD
- BIRK -0.40
- ASND -0.62
- Stochastic Oscillator
- BIRK 9.70
- ASND 52.65
About BIRK Birkenstock Holding plc
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.